1-hydroxymethylmidazolam has been researched along with 1-hydroxymethylmidazolam glucuronide in 3 studies
| Studies (1-hydroxymethylmidazolam) | Trials (1-hydroxymethylmidazolam) | Recent Studies (post-2010) (1-hydroxymethylmidazolam) | Studies (1-hydroxymethylmidazolam glucuronide) | Trials (1-hydroxymethylmidazolam glucuronide) | Recent Studies (post-2010) (1-hydroxymethylmidazolam glucuronide) |
|---|---|---|---|---|---|
| 163 | 46 | 49 | 6 | 3 | 2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Hoog, M; de Wildt, SN; van den Anker, JN; van der Giesen, E; Vinks, AA | 1 |
| Goh, BC; Hee, KH; Lee, LS; Sapari, NS; Seng, KY; Soon, GH; Soong, R | 1 |
| Baar, FPM; de Winter, BCM; Franken, LG; Koch, BCP; Masman, AD; Mathot, RAA; Tibboel, D; van Gelder, T | 1 |
2 trial(s) available for 1-hydroxymethylmidazolam and 1-hydroxymethylmidazolam glucuronide
| Article | Year |
|---|---|
CYP3A5*3 and bilirubin predict midazolam population pharmacokinetics in Asian cancer patients.
Topics: Adult; Aged; Anti-Anxiety Agents; Asian People; Bilirubin; Body Weight; Creatinine; Cytochrome P-450 CYP3A; Female; Genotype; Glucuronosyltransferase; Humans; Injections, Intravenous; Male; Midazolam; Middle Aged; Neoplasms; Polymorphism, Genetic | 2014 |
Hypoalbuminaemia and decreased midazolam clearance in terminally ill adult patients, an inflammatory effect?
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Dose-Response Relationship, Drug; Drug Dosage Calculations; Female; Glomerular Filtration Rate; Humans; Hypnotics and Sedatives; Hypoalbuminemia; Injections, Subcutaneous; Male; Metabolic Clearance Rate; Midazolam; Middle Aged; Nonlinear Dynamics; Palliative Care; Precision Medicine; Renal Elimination; Terminally Ill; Time Factors | 2017 |
1 other study(ies) available for 1-hydroxymethylmidazolam and 1-hydroxymethylmidazolam glucuronide
| Article | Year |
|---|---|
Population pharmacokinetics and metabolism of midazolam in pediatric intensive care patients.
Topics: Adolescent; Aryl Hydrocarbon Hydroxylases; Bayes Theorem; Child; Child, Preschool; Conscious Sedation; Critical Care; Cytochrome P-450 CYP3A; Female; Humans; Hypnotics and Sedatives; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Liver Failure; Male; Mathematical Computing; Metabolic Clearance Rate; Midazolam; Oxidoreductases, N-Demethylating; Renal Insufficiency | 2003 |